A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/454 (2006.01) A61K 39/395 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2659774
The treatment, prevention or management of mantle cell lymphomas by administration of an immunomodulatory compound of the invention known as Revlimid® or lenalidomide are disclosed. The invention further relates to the use of this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy for the claimed treatment. Pharmaceutical compositions and single unit dosage forms suitable for use in the invention are also disclosed.
L'invention concerne des procédés de traitement, de prévention ou de prise en charge de lymphomes à cellules du manteau. Ces procédés comprennent l'administration d'un composé immunomodulateur de l'invention, appelé Revlimid® ou lénalidomide. L'invention concerne en outre des procédés de traitement utilisant ce composé avec une chimiothérapie, une radiothérapie, une hormonothérapie, une biothérapie ou une immunothérapie. Elle concerne également des compositions pharmaceutiques et des formes de doses unitaires individuelles utilisables dans les procédés de l'invention.
Celgene Corporation
Smart & Biggar
LandOfFree
Use of 3-... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 3-..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 3-... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1373196